메뉴 건너뛰기




Volumn 86, Issue 5, 2002, Pages 1113-1129

The use of anti-IgE in the treatment of allergic asthma

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CGP 51901; CORTICOSTEROID; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; METHACHOLINE; OMALIZUMAB; PLACEBO; UNCLASSIFIED DRUG; ZOLAIR;

EID: 0036711139     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(02)00036-6     Document Type: Review
Times cited : (15)

References (41)
  • 1
    • 0024491638 scopus 로고
    • Association of asthma with serum IgE levels and skin-test reactivity to allergens
    • Burrows B, Martinez FD, Halonen M, et al. Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Engl J Med 1989;320:271-7.
    • (1989) N Engl J Med , vol.320 , pp. 271-277
    • Burrows, B.1    Martinez, F.D.2    Halonen, M.3
  • 2
    • 0030047113 scopus 로고    scopus 로고
    • House dust mite allergens: A major risk factor for childhood asthma in Australia
    • Peat JK, Tovey E, Toelle GB, et al. House dust mite allergens: A major risk factor for childhood asthma in Australia. Am J Respir Crit Care Med 1996;153:141-6.
    • (1996) Am J Respir Crit Care Med , vol.153 , pp. 141-146
    • Peat, J.K.1    Tovey, E.2    Toelle, G.B.3
  • 3
    • 0026051430 scopus 로고
    • Relationship between airway responsiveness and serum IgE in children with asthma and in apparently normal children
    • Sears MR, Burrows B, Flannery EM, et al. Relationship between airway responsiveness and serum IgE in children with asthma and in apparently normal children. N Engl J Med 1991;325:1067-71.
    • (1991) N Engl J Med , vol.325 , pp. 1067-1071
    • Sears, M.R.1    Burrows, B.2    Flannery, E.M.3
  • 4
    • 0025004551 scopus 로고
    • Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood
    • Sporik R, Holgate ST, Platts-Mills TAE, et al. Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. N Engl J Med 1990;323:502-7.
    • (1990) N Engl J Med , vol.323 , pp. 502-507
    • Sporik, R.1    Holgate, S.T.2    Platts-Mills, T.A.E.3
  • 5
    • 0026540917 scopus 로고
    • Variations in asthma hospitalizations and death in New York
    • Carr W, Zeitel L, Weiss K. Variations in asthma hospitalizations and death in New York. Am J Public Health 1992;82:59-65.
    • (1992) Am J Public Health , vol.82 , pp. 59-65
    • Carr, W.1    Zeitel, L.2    Weiss, K.3
  • 6
    • 0028870592 scopus 로고
    • Asthma and wheezing in the first six years of life
    • The Group Health Medical Associates
    • Martinez FD, Wright AL, Taussig LM, et al. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 1995;332:133-8.
    • (1995) N Engl J Med , vol.332 , pp. 133-138
    • Martinez, F.D.1    Wright, A.L.2    Taussig, L.M.3
  • 7
    • 0019948077 scopus 로고
    • Reduction of bronchial hyperactivity during prolonged allergen avoidance
    • Platts Mills TAE, Tovey ER, Mitchell EB, et al. Reduction of bronchial hyperactivity during prolonged allergen avoidance. Lancet 1982;2:675-8.
    • (1982) Lancet , vol.2 , pp. 675-678
    • Platts Mills, T.A.E.1    Tovey, E.R.2    Mitchell, E.B.3
  • 8
    • 0001925097 scopus 로고    scopus 로고
    • Antigen-induced airway disease
    • Bush RK, editor. New York: Marcel Dekker
    • Kiekhaefer CM, Kelly EA, Jarjour NN. Antigen-induced airway disease. In: Bush RK, editor. Environmental asthma. New York: Marcel Dekker; 2001. p. 13-31.
    • (2001) Environmental Asthma , pp. 13-31
    • Kiekhaefer, C.M.1    Kelly, E.A.2    Jarjour, N.N.3
  • 9
    • 0031955159 scopus 로고    scopus 로고
    • An overview of antigen presentation and its central role in the immune response
    • Whitton JL. An overview of antigen presentation and its central role in the immune response. Curr Top Microbiol Immunol 1998;232:1-4.
    • (1998) Curr Top Microbiol Immunol , vol.232 , pp. 1-4
    • Whitton, J.L.1
  • 10
    • 0022640843 scopus 로고
    • Two types of murine helper T-cell clones: Definition according to profiles of lymphokine activities and secreted proteins
    • Mosmann TR, Cherwinski H, Bond MW, et al. Two types of murine helper T-cell clones: Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-57.
    • (1986) J Immunol , vol.136 , pp. 2348-2357
    • Mosmann, T.R.1    Cherwinski, H.2    Bond, M.W.3
  • 11
    • 0033118157 scopus 로고    scopus 로고
    • Helper T-cell differentiation
    • Swain SL. Helper T-cell differentiation. Curr Opin Immunol 1999;11:180-5.
    • (1999) Curr Opin Immunol , vol.11 , pp. 180-185
    • Swain, S.L.1
  • 12
    • 0032615726 scopus 로고    scopus 로고
    • B7 costimulation is required for IL-5 and IL-13 secretion by bronchial biopsy tissue of atopic asthmatic subjects in response to allergen stimulation
    • Jaffar Z, Roberts K, Pandit A, et al. B7 costimulation is required for IL-5 and IL-13 secretion by bronchial biopsy tissue of atopic asthmatic subjects in response to allergen stimulation. Am J Respir Cell Mol Biol 1999;20:153-62.
    • (1999) Am J Respir Cell Mol Biol , vol.20 , pp. 153-162
    • Jaffar, Z.1    Roberts, K.2    Pandit, A.3
  • 13
    • 0030922681 scopus 로고    scopus 로고
    • Costimulation through B7-2 (CD86) is required for the induction of a lung mucosal T helper cell 2 (TH2) immune response and altered airway responsiveness
    • Tsuyuki S, Tsuyuki J, Einsle K, et al. Costimulation through B7-2 (CD86) is required for the induction of a lung mucosal T helper cell 2 (TH2) immune response and altered airway responsiveness. J Exp Med 1997;185:1671-9.
    • (1997) J Exp Med , vol.185 , pp. 1671-1679
    • Tsuyuki, S.1    Tsuyuki, J.2    Einsle, K.3
  • 14
    • 0033043179 scopus 로고    scopus 로고
    • Development of T-cell memory against inhalant allergens: Risks for future
    • Holt PG. Development of T-cell memory against inhalant allergens: Risks for future. Clin Exp Allergy 1999;29(suppl 2):8-13.
    • (1999) Clin Exp Allergy , vol.29 , Issue.SUPPL. 2 , pp. 8-13
    • Holt, P.G.1
  • 16
    • 0025085559 scopus 로고
    • Circadian basis of the late phase asthmatic response
    • Mohiuddin AA, Martin RJ. Circadian basis of the late phase asthmatic response. Am Rev Respir Dis 1990;142:1153-7.
    • (1990) Am Rev Respir Dis , vol.142 , pp. 1153-1157
    • Mohiuddin, A.A.1    Martin, R.J.2
  • 17
    • 0035888742 scopus 로고    scopus 로고
    • The role of immunoglobulin E in allergy and asthma
    • Platts-Mills TAE. The role of immunoglobulin E in allergy and asthma. Am J Respir Crit Care Med 2001;164:S1-5.
    • (2001) Am J Respir Crit Care Med , vol.164
    • Platts-Mills, T.A.E.1
  • 18
    • 0034872296 scopus 로고    scopus 로고
    • Molecular and cellular mechanisms of allergic disease
    • Broide DH. Molecular and cellular mechanisms of allergic disease. J Allergy Clin Immunol 2001;108:S65-71.
    • (2001) J Allergy Clin Immunol , vol.108
    • Broide, D.H.1
  • 19
    • 17644441947 scopus 로고    scopus 로고
    • The effect of intravenous administration of a chimeric anti-IgE antibody on serum IgE levels in atopic subjects: Efficacy, safety, and pharmacokinetics
    • Corne J, Djukanovic R, Thomas L, et al. The effect of intravenous administration of a chimeric anti-IgE antibody on serum IgE levels in atopic subjects: Efficacy, safety, and pharmacokinetics. J Clin Invest 1997;99:879-87.
    • (1997) J Clin Invest , vol.99 , pp. 879-887
    • Corne, J.1    Djukanovic, R.2    Thomas, L.3
  • 20
  • 21
    • 0031670214 scopus 로고    scopus 로고
    • Treatment of allergic airways disease with anti-IgE
    • Holgate SL, Corne J, Jardieu P, et al. Treatment of allergic airways disease with anti-IgE. Allergy 1998;53:83-8.
    • (1998) Allergy , vol.53 , pp. 83-88
    • Holgate, S.L.1    Corne, J.2    Jardieu, P.3
  • 22
    • 0035888750 scopus 로고    scopus 로고
    • Development of a monoclonal anti-immunoglobulin E antibody (omalizumab) for the treatment of allergic respiratory disorders
    • Schulman ES. Development of a monoclonal anti-immunoglobulin E antibody (omalizumab) for the treatment of allergic respiratory disorders. Am J Respir Crit Care Med 2001;164:S6-S11.
    • (2001) Am J Respir Crit Care Med , vol.164
    • Schulman, E.S.1
  • 23
    • 0029045956 scopus 로고
    • Anti-IgE monoclonal antibodies that inhibit allergen-specific histamine release
    • Shields RL, Werther WR, Zioncheck K, et al. Anti-IgE monoclonal antibodies that inhibit allergen-specific histamine release. Int Arch Allergy Immunol 1995;107:412-3.
    • (1995) Int Arch Allergy Immunol , vol.107 , pp. 412-413
    • Shields, R.L.1    Werther, W.R.2    Zioncheck, K.3
  • 24
    • 0031065108 scopus 로고    scopus 로고
    • Down-regulation of FcεRI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody
    • MacGlashan DWJ, Bochner BS, Adelman DC, et al. Down-regulation of FcεRI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. J Immunol 1997;158:1438-45.
    • (1997) J Immunol , vol.158 , pp. 1438-1445
    • MacGlashan, D.W.J.1    Bochner, B.S.2    Adelman, D.C.3
  • 25
    • 0000655807 scopus 로고
    • Pharmacokinetics/dynamics following administration of a recombinant humanized monoclonal anti IgE antibody in the cynomolgus monkey
    • Schoenhoff M, Bates D, Rupel J, et al. Pharmacokinetics/dynamics following administration of a recombinant humanized monoclonal anti IgE antibody in the cynomolgus monkey [abstract]. J Allergy Clin Immunol 1995;356.
    • (1995) J Allergy Clin Immunol , pp. 356
    • Schoenhoff, M.1    Bates, D.2    Rupel, J.3
  • 26
    • 0001656661 scopus 로고
    • Initial human study with a humanized recombinant anti-IgE monoclonal antibody: Safety, tolerance and pharmacokinetic (PK)/dynamic profile
    • Froehlich J, Schoenhoff M, Tremblay T, et al. Initial human study with a humanized recombinant anti-IgE monoclonal antibody: Safety, tolerance and pharmacokinetic (PK)/ dynamic profile. Clin Pharmacol Ther 1995;57:162.
    • (1995) Clin Pharmacol Ther , vol.57 , pp. 162
    • Froehlich, J.1    Schoenhoff, M.2    Tremblay, T.3
  • 27
    • 0000655808 scopus 로고
    • Multiple doses of a recombinant humanized monoclonal anti IgE antibody are safely tolerated and decrease free serum IgE to undetectable levels
    • Froehlich J, Schoenhoff M, Jardieu P, et al. Multiple doses of a recombinant humanized monoclonal anti IgE antibody are safely tolerated and decrease free serum IgE to undetectable levels [abstract]. J Allergy Clin Immunol 1995;356.
    • (1995) J Allergy Clin Immunol , pp. 356
    • Froehlich, J.1    Schoenhoff, M.2    Jardieu, P.3
  • 28
    • 0001526474 scopus 로고    scopus 로고
    • Anti-IgE treatment reduces skin test (ST) reactivity
    • Togias A, Corren J, Shapiro G, et al. Anti-IgE treatment reduces skin test (ST) reactivity [abstract]. J Allergy Clin Immunol 1998;101:S171.
    • (1998) J Allergy Clin Immunol , vol.101
    • Togias, A.1    Corren, J.2    Shapiro, G.3
  • 29
    • 8244226656 scopus 로고    scopus 로고
    • Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response
    • Boulet LP, Chapman KR, Cote J, et al. Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response. Am J Respir Crit Care Med 1997;155:1835-40.
    • (1997) Am J Respir Crit Care Med , vol.155 , pp. 1835-1840
    • Boulet, L.P.1    Chapman, K.R.2    Cote, J.3
  • 30
    • 0030956903 scopus 로고    scopus 로고
    • The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects
    • Fahy JV, Fleming HE, Wong HH, et al. The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects. Am J Respir Crit Care Med 1997;155:1828-34.
    • (1997) Am J Respir Crit Care Med , vol.155 , pp. 1828-1834
    • Fahy, J.V.1    Fleming, H.E.2    Wong, H.H.3
  • 31
    • 0032849367 scopus 로고    scopus 로고
    • Effect of aerosolized anti-IgE (E25) on airway responses to inhaled allergen in asthmatic subjects
    • Fahy JV, Cockcroft DW, Boulet L-P, et al. Effect of aerosolized anti-IgE (E25) on airway responses to inhaled allergen in asthmatic subjects. Am J Respir Crit Care Med 1999; 160:1023-7.
    • (1999) Am J Respir Crit Care Med , vol.160 , pp. 1023-1027
    • Fahy, J.V.1    Cockcroft, D.W.2    Boulet, L.-P.3
  • 32
    • 0034864618 scopus 로고    scopus 로고
    • Experiences with monoclonal antibody therapy for allergic asthma
    • Boushey Jr HA. Experiences with monoclonal antibody therapy for allergic asthma. J Allergy Clin Immunol 2001;108:S77-83.
    • (2001) J Allergy Clin Immunol , vol.108
    • Boushey H.A., Jr.1
  • 33
    • 0035888741 scopus 로고    scopus 로고
    • Anti-immunoglobulin E (omalizumab) therapy in allergic asthma
    • Busse WW. Anti-immunoglobulin E (omalizumab) therapy in allergic asthma. Am J Respir Crit Care Med 2001;164:S12-7.
    • (2001) Am J Respir Crit Care Med , vol.164
    • Busse, W.W.1
  • 34
    • 0033599043 scopus 로고    scopus 로고
    • Treatment of allergic asthma with monoclonal antiIgE antibody
    • Milgrom H, Fick Jr RB, Su JQ, et al. Treatment of allergic asthma with monoclonal antiIgE antibody. N Engl J Med 1999;341:1966-73.
    • (1999) N Engl J Med , vol.341 , pp. 1966-1973
    • Milgrom, H.1    Fick R.B., Jr.2    Su, J.Q.3
  • 35
    • 0034907372 scopus 로고    scopus 로고
    • Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma
    • Busse W, Corren J, Lanier BQ, et al. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol 2001; 108:184-90.
    • (2001) J Allergy Clin Immunol , vol.108 , pp. 184-190
    • Busse, W.1    Corren, J.2    Lanier, B.Q.3
  • 36
    • 0035434688 scopus 로고    scopus 로고
    • Treatment of childhood asthma with antiimmunoglobulin E antibody (omalizumab)
    • Milgrom H, Berger W, Nayak A, et al. Treatment of childhood asthma with antiimmunoglobulin E antibody (omalizumab). Pediatrics Electronic 2001;108:1-10.
    • (2001) Pediatrics Electronic , vol.108 , pp. 1-10
    • Milgrom, H.1    Berger, W.2    Nayak, A.3
  • 37
    • 0034881877 scopus 로고    scopus 로고
    • The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics
    • Solèr M, Matz J, Townley R, et al. The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics. Eur Respir J 2001;18:254-61.
    • (2001) Eur Respir J , vol.18 , pp. 254-261
    • Solèr, M.1    Matz, J.2    Townley, R.3
  • 38
    • 0033836319 scopus 로고    scopus 로고
    • Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen-induced seasonal allergic rhinitis
    • Adelroth E, Rak S, Haahtela T, et al. Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen-induced seasonal allergic rhinitis. J Allergy Clin Immunol 2000; 106:253-9.
    • (2000) J Allergy Clin Immunol , vol.106 , pp. 253-259
    • Adelroth, E.1    Rak, S.2    Haahtela, T.3
  • 39
    • 0034878976 scopus 로고    scopus 로고
    • Experience with monoclonal antibodies in allergic mediated disease: Seasonal allergic rhinitis
    • Casale TB. Experience with monoclonal antibodies in allergic mediated disease: Seasonal allergic rhinitis. J Allergy Clin Immunol 2001;108:S84-8.
    • (2001) J Allergy Clin Immunol , vol.108
    • Casale, T.B.1
  • 40
    • 0030853854 scopus 로고    scopus 로고
    • Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis
    • Casale TB, Bernstein IL, Busse WW, et al. Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis. J Allergy Clin Immunol 1997;100:110-21.
    • (1997) J Allergy Clin Immunol , vol.100 , pp. 110-121
    • Casale, T.B.1    Bernstein, I.L.2    Busse, W.W.3
  • 41
    • 0036174045 scopus 로고    scopus 로고
    • Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis
    • Kuehr J, Brauburger J, Zielen S, et al. Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis. J Allergy Clin Immunol 2002;109:274-80.
    • (2002) J Allergy Clin Immunol , vol.109 , pp. 274-280
    • Kuehr, J.1    Brauburger, J.2    Zielen, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.